4//SEC Filing
Amman Bradford K. 4
Accession 0001493152-21-012902
CIK 0001716166other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 9:45 PM ET
Size
8.9 KB
Accession
0001493152-21-012902
Insider Transaction Report
Form 4
Amman Bradford K.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-05-25$5.29/sh+1,000$5,290→ 2,000 total
Holdings
- 100,000
Stock Option
Exercise: $7.50Exp: 2026-03-12→ Common Stock (100,000 underlying) - 83,334
Stock Option
Exercise: $7.50Exp: 2023-10-22→ Common Stock (83,334 underlying) - 16,667
Stock Option
Exercise: $7.50Exp: 2024-11-18→ Common Stock (16,667 underlying)
Footnotes (3)
- [F1]100,000 stock options granted on March 12, 2021. One-fifth vested immediately and one-fifth vests annually on each anniversary date through March 12, 2025.
- [F2]16,667 stock options granted on November 18, 2019. One-fifth vested immediately and one-fifth vests annually on each anniversary date through November 18, 2023.
- [F3]83,334 stock options granted on November 18, 2019. One-fifth vested immediately and one-fifth vests annually on each anniversary date through October 22, 2022.
Documents
Issuer
Vivos Therapeutics, Inc.
CIK 0001716166
Entity typeother
Related Parties
1- filerCIK 0001425339
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 9:45 PM ET
- Size
- 8.9 KB